-
Mashup Score: 1Episode 358: VISIBL-MS with Dr. Jaime Imitola - 4 month(s) ago
The inequities associated with gaining access to quality healthcare are often discussed, and my guest this week has taken steps to address them. Dr. Jaime Imitola and his team at UCONN Health have created a tool called VISIBL-MS, a bilingual framework designed to increase doctors’ and patients’ awareness of the early signs of MS. We’ll also share the results of a study that clearly illustrate progression independent of relapse activity (PIRA). We’ll tell you about a small study that showed a positive outcome for people with progressive MS who received neural stem cell therapy. We’ll share details of a study that identified a panel of 20 blood-based proteins that have been shown to be predictive of MS disease activity. (And we’ll tell you why that’s a good thing for patients and researchers!) And we’re reminding you that we’re just over 2 weeks away from CRUSH MS! We have a lot to talk about! Are you ready for RealTalk MS??! This Week: VISIBL-MS :22 Study results provide evidence of PI
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 3Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology - 5 month(s) ago
In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI’s use in sleep neurology.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet-
Want to know what’s coming up in our new issue? Listen to the #NeurologyToday in 5 #podcast now to find out! https://t.co/40MHFhGseL #NeuroTwitter @AANMember @BrainHealthMD https://t.co/RUqWwwMGRk
-
-
Mashup Score: 7Thriving with Type 1 Diabetes: A Focus on Teens - 5 month(s) ago
Tune in to the latest episode of Diabetes Day by Day! Hosts Dr. Neil Skolnik and Dr. Sara Wettergreen tackle the unique challenges faced by teens with type 1 diabetes and offer valuable insights on overcoming them. Joined by Nathan Bekelman, a teenager living with type 1 diabetes, who shares his inspiring personal journey. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Nathan Bekelman, Teenager living with type 1 diabetes Do you have questions or comments you’d like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening
Source: traffic.libsyn.comCategories: General Medicine News, EndocrinologyTweet-
Don't miss our latest episode of #DiabetesDayByDay, Thriving with Type 1 Diabetes: A Focus on Teens. Our hosts and special guest share strategies on how to navigate the unique challenges faced by teens with type 1 diabetes and more. Tune in now at https://t.co/J6Ac5GRxX5. 🎧 https://t.co/8OO9n3oTEM
-
-
Mashup Score: 4When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs. - 5 month(s) ago
In this week’s podcast, Neurology Today’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet-
Want to know what’s coming up in our next issue? Listen to the latest episode of the #NeurologyToday in 5 #podcast, featuring our editor in chief, @BrainHealthMD: https://t.co/BEodFhV6go #NeuroTwitter @AANMember https://t.co/V4mR1qokZJ
-
-
Mashup Score: 2Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics - 6 month(s) ago
In this week’s podcast, Neurology Today’s editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet-
Get a sneak peek at Thursday’s new issue with the #NeurologyTodayIn5 podcast, hosted by our editor in chief, @BrainHealthMD: https://t.co/8lgC2lS4M2 #NeuroTwitter @AANMember https://t.co/M4SXbyXoI6
-
-
Mashup Score: 3Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers - 6 month(s) ago
In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet-
Tune into the #NeurologyToday in 5 #podcast for a look at this week’s new issue with our editor in chief, @BrainHealthMD: https://t.co/7Lw2Lg5sxN #NeuroTwitter @AANMember https://t.co/k0Oqal1XVi
-
-
Mashup Score: 5Prediabetes: When Action is the Best Medicine - 6 month(s) ago
In the latest episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen take a deep dive into strategies aimed at reducing the risk of progressing from prediabetes to type 2 diabetes. An astounding 1 in 3 American adults, approximately 98 million, are living with prediabetes. Alarmingly, 80% of them are unaware of their condition. This issue demands attention because, without intervention, many people living with prediabetes may progress to type 2 diabetes in as little as 5 years. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do
Source: traffic.libsyn.comCategories: General Medicine News, EndocrinologyTweet-
Tune in to our latest special edition episode of #DiabetesDayByDay, Prediabetes: When Action is the Best Medicine. Join our hosts as they discuss strategies aimed at reducing the risk of progressing from prediabetes to type 2 diabetes. Listen now at https://t.co/vmGqC03nuo. 🎧 https://t.co/4w1WoPADLa
-
-
Mashup Score: 0Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies - 7 month(s) ago
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors’ response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet-
Grab your headphones and tune into the #NeurologyToday in 5 #podcast, where our editor in chief, @BrainHealthMD, shares a sneak peek at this Thursday’s new issue: https://t.co/iMOg9ySUHs #NeuroTwitter @AANMember https://t.co/M9sa8GZf9R
-
-
Mashup Score: 2ME/CFS and long COVID; negative outcomes for ALS drug; donanemab - 7 month(s) ago
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer’s disease.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet-
Tune into the #NeurologyToday in 5 #podcast for a sneak peek of our April 18 issue with our editor in chief, @BrainHealthMD: https://t.co/3odTyQud30 #NeuroTwitter @AANMember https://t.co/Ba8cgsglND
-
-
Mashup Score: 10Special Edition: A Focus on Obesity. Part 3: Talking to your Doctor About Obesity Treatment - 7 month(s) ago
In this insightful episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen delve into the newest approaches to discussing obesity treatments with your doctor and strategies for effectively planning this conversation. They are joined by Aaron Sutton, a behavioral health consultant, and Tamika Holland, who shares her personal journey with obesity. This is the third episode of a three-part series of Diabetes Day by Day that focuses on recognizing obesity as a chronic disease that requires treatment. Learn about strategies for tackling obesity, preparing for doctor’s appointments, and overcoming the hurdles associated with initiating conversations about obesity. Discover more about medications and other innovative treatment options that provide renewed hope and much more. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise a total of seven episodes
Source: traffic.libsyn.comCategories: General Medicine News, EndocrinologyTweet-
Tune in to our latest special edition episode of #DiabetesDayByDay, A Focus on Obesity. Part 3: Talking to your Doctor About Obesity Treatment, which is a collaborative effort between the ADA and @aafp. Listen now at https://t.co/6jzkA8mCSX. 🎧 @LillyPad @novonordisk https://t.co/FqWNbWEMIX
-
RT @RealTalkMS_jon: https://t.co/oVW08OgtQ1 Dr.Jaime Imitola and his team at UCONN Health created a tool called VISIBL-MS, a bilingual fram…